Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors.

BMC Cancer · 2020 · PMC7532092 · PMID 33008336

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

While an evaluation of the incidence rates of CRC in the USA shows a decreasing trend between 2000 and 2014 [ 1 ] what is most worrying, is that in the last 60 years, CRC has been on the rise in the under 50 population [ 1 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.